These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 25170267)
1. Sulfatide-containing lipid perfluorooctylbromide nanoparticles as paclitaxel vehicles targeting breast carcinoma. Li X; Qin F; Yang L; Mo L; Li L; Hou L Int J Nanomedicine; 2014; 9():3971-85. PubMed ID: 25170267 [TBL] [Abstract][Full Text] [Related]
2. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response. Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN Drug Dev Ind Pharm; 2017 Dec; 43(12):1952-1962. PubMed ID: 28724314 [TBL] [Abstract][Full Text] [Related]
3. Co-Delivery of Gemcitabine and Paclitaxel in cRGD-Modified Long Circulating Nanoparticles with Asymmetric Lipid Layers for Breast Cancer Treatment. Zhang J; Zhang P; Zou Q; Li X; Fu J; Luo Y; Liang X; Jin Y Molecules; 2018 Nov; 23(11):. PubMed ID: 30405089 [TBL] [Abstract][Full Text] [Related]
4. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy. Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055 [No Abstract] [Full Text] [Related]
5. Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells. Mitra M; Misra R; Harilal A; Sahoo SK; Krishnakumar S Mol Vis; 2011; 17():2724-37. PubMed ID: 22065926 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid). Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829 [TBL] [Abstract][Full Text] [Related]
7. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation. Jiang X; Xin H; Sha X; Gu J; Jiang Y; Law K; Chen Y; Chen L; Wang X; Fang X Int J Pharm; 2011 Nov; 420(2):385-94. PubMed ID: 21920419 [TBL] [Abstract][Full Text] [Related]
8. Unveiling the potential of ursolic acid modified hyaluronate nanoparticles for combination drug therapy in triple negative breast cancer. Sharma R; Yadav V; Jha S; Dighe S; Jain S Carbohydr Polym; 2024 Aug; 338():122196. PubMed ID: 38763723 [TBL] [Abstract][Full Text] [Related]
9. Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery. Song N; Liu W; Tu Q; Liu R; Zhang Y; Wang J Colloids Surf B Biointerfaces; 2011 Oct; 87(2):454-63. PubMed ID: 21719259 [TBL] [Abstract][Full Text] [Related]
10. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells. Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697 [TBL] [Abstract][Full Text] [Related]
11. PEGylated-Paclitaxel and Dihydroartemisinin Nanoparticles for Simultaneously Delivering Paclitaxel and Dihydroartemisinin to Colorectal Cancer. Phung CD; Le TG; Nguyen VH; Vu TT; Nguyen HQ; Kim JO; Yong CS; Nguyen CN Pharm Res; 2020 Jun; 37(7):129. PubMed ID: 32548664 [TBL] [Abstract][Full Text] [Related]
12. Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma. Shi L; Tang C; Yin C Biomaterials; 2012 Oct; 33(30):7594-604. PubMed ID: 22796165 [TBL] [Abstract][Full Text] [Related]
13. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer. Min SY; Byeon HJ; Lee C; Seo J; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS Int J Pharm; 2015 Oct; 494(1):506-15. PubMed ID: 26315118 [TBL] [Abstract][Full Text] [Related]
14. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery. Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039 [TBL] [Abstract][Full Text] [Related]
15. iRGD-Guided Silica/Gold Nanoparticles for Efficient Tumor-Targeting and Enhancing Antitumor Efficacy Against Breast Cancer. Hou X; Chen Q; Fang Y; Zhang L; Huang S; Xu M; Ren Y; Shi Z; Wei Y; Li L Int J Nanomedicine; 2024; 19():8237-8251. PubMed ID: 39157735 [TBL] [Abstract][Full Text] [Related]
16. Co-delivery of paclitaxel (PTX) and docosahexaenoic acid (DHA) by targeting lipid nanoemulsions for cancer therapy. Li B; Tan T; Chu W; Zhang Y; Ye Y; Wang S; Qin Y; Tang J; Cao X Drug Deliv; 2022 Dec; 29(1):75-88. PubMed ID: 34964421 [TBL] [Abstract][Full Text] [Related]
17. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo. Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098 [TBL] [Abstract][Full Text] [Related]
18. Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma. Pandey V; Gajbhiye KR; Soni V Drug Deliv; 2015 Feb; 22(2):199-205. PubMed ID: 24467582 [TBL] [Abstract][Full Text] [Related]
19. tLyP-1 Peptide Functionalized Human H Chain Ferritin for Targeted Delivery of Paclitaxel. Ma Y; Li R; Dong Y; You C; Huang S; Li X; Wang F; Zhang Y Int J Nanomedicine; 2021; 16():789-802. PubMed ID: 33568906 [TBL] [Abstract][Full Text] [Related]
20. An organic solvent-free technology for the fabrication of albumin-based paclitaxel nanoparticles for effective cancer therapy. Zhao Y; Cai C; Liu M; Zhao Y; Pei W; Chu X; Zhang H; Wang Z; Han J Colloids Surf B Biointerfaces; 2019 Nov; 183():110394. PubMed ID: 31398618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]